BostonGene
Tumor Portrait sequences your tumor's DNA and RNA and compares it with your normal DNA from saliva, a cheek swab or blood. Your doctor orders it. In October 2026 my cost was $4,500 out of pocket.
All organizations
Treatment & Testing16 organizations
Company
Caris Life Sciences
Caris tests tumor tissue or blood, reading the whole exome and transcriptome to look for changes that point to targeted drugs, immunotherapy or trials. Your oncologist orders it.
Echo Immune
Echo Immune designs and makes personalized mRNA cancer vaccines for patients with solid tumors, handling sequencing, design, manufacturing, FDA paperwork and immune monitoring.
In research
Future of Cancer Care Today
Free research support for patients exploring diagnostics, treatments, and the people who can help.
Guardant Health
Blood and tissue tests to find tumor biomarkers. Separate tests track residual disease and treatment response.
Inocras
CancerVision compares tumor and normal DNA using whole-genome sequencing, with report support and trial matching.
Jaime Leandro Foundation
JLF helps patients explore personalized cancer vaccines and coordinates the testing, design, manufacturing and doctors involved. Its program uses peptide vaccines.
In research
Jiyu Bio
Helps patients find cancer trials in China and coordinate the paperwork, travel and care-team handoffs.
Natera (Signatera)
Natera's Signatera is a personalized blood test, built from your tumor, that looks for traces of tumor DNA to check for remaining cancer, track treatment and catch a recurrence earlier. Your doctor orders it.
Palitra
Tests treatment options on tumor cells to help explore drug combinations.
Relit Biosciences
Explores biomarker-targeted imaging and radioligand approaches.
Selvana
Develops blood-based tracking of a cancer’s presence, amount and changes over time.
Serova
Serova designs a personalized mRNA cancer vaccine from your tumor data and helps your doctor seek FDA permission to give it. The first review of your reports is free. The vaccine is experimental, and as of September 2026 no patient had received it.
In research
Sophont
Holon-S1 uses AI to infer spatial gene-expression patterns from digitized pathology slides. Research only.
In research
Travera
Tests drugs on live tumor cells outside the body and returns a report to the ordering physician.
Valius Sciences
Deep tumor profiling across DNA, RNA and proteins, using existing fixed tissue.